This paper presents a comprehensive obstetric case study of a 26-year-old Caucasian woman at 33 weeks gestation diagnosed with genital herpes (HSV type 2). Using an episodic SOAP note format, the paper documents the patient's history, physical examination findings, laboratory results, primary and differential diagnoses, and a multidisciplinary management plan. Key topics include antiviral therapy with Acyclovir, neonatal transmission risk, patient education on prevention, and the importance of collaborative care involving maternal-fetal medicine and infectious disease specialists. The paper concludes with a reflective discussion on evidence-based practice, patient-centered education, and the unique complexities of managing sexually transmitted infections during pregnancy.
This paper demonstrates clinical reasoning through differential diagnosis construction. Rather than simply asserting the primary diagnosis, the author systematically considers bacterial vaginosis, contact dermatitis, and UTI, then uses specific clinical and laboratory features to rule each out. This approach shows scholarly rigor and mirrors real-world diagnostic practice.
The paper opens with an introduction framing the case, followed by a full SOAP note that moves through subjective history, objective examination findings, assessment with primary and differential diagnoses, and a detailed management plan. A closing reflection section addresses professional learning, health promotion considerations, and future practice implications. References follow APA formatting throughout.
This comprehensive obstetric case study centers on a 26-year-old Caucasian female who is currently 33 weeks pregnant. The patient sought medical attention due to symptoms raising suspicion of genital herpes (HSV type 2). This paper provides a thorough analysis of the patient's health status, medical history, physical examination findings, and laboratory results. It also explores differential diagnoses, an evidence-based management plan, patient education strategies, and proposed follow-up care. Throughout, the treatment plan is grounded in evidence-based guidelines from reputable sources.
MG is a 26-year-old married Caucasian female.
MG presented to the clinic stating, "I have come for my lab results." She sought clarification regarding her recent laboratory workup, specifically the results related to her symptoms of genital discomfort, itching, and painful sores. This raised concern for a potential diagnosis of genital herpes (HSV type 2).
MG is a 26-year-old Caucasian female at 33 weeks of pregnancy who reports experiencing symptoms of genital herpes in the genital area. The painful sores and itching are localized to the vulva and surrounding areas, and she has not noticed any similar lesions or discomfort in other regions of her body. The patient recalls that symptoms began approximately two weeks ago. She first noticed a tingling sensation in her genital area, which was soon followed by the appearance of small red bumps that quickly progressed into painful, fluid-filled vesicles. The sudden onset of these symptoms raised concern, prompting her to seek medical attention promptly.
The character of the patient's symptoms is described as painful sores and intense itching. The sores are small, raised, and fluid-filled, causing discomfort and tenderness. The patient further explains that the lesions tend to break open, leading to painful ulcers that eventually crust over before healing. Since their onset two weeks ago, she has noticed a cyclic pattern of exacerbation and partial relief. The intensity of symptoms has varied throughout the day and worsens after prolonged sitting or wearing tight-fitting clothing. MG rates the severity of her symptoms as 6/10. The pain is significant enough to interfere with her daily activities, though she manages with over-the-counter pain relievers and sitz baths, which provide some relief.
MG is not taking any medications besides the recently prescribed Acyclovir 400 mg orally three times a day for 7 days to manage the active herpes outbreak. She has not yet started the medication but is eager to begin. She denies any known allergies to medications, foods, or environmental triggers, and reports prior use of Acyclovir for a non-related condition without adverse reactions.
MG's past medical history is relatively unremarkable. She recalls experiencing occasional seasonal allergies characterized by sneezing and mild nasal congestion, and during her teenage years she had an episode of mononucleosis that resolved without complications. There are no significant prior illnesses, surgeries, or hospitalizations. She reports adhering to regular prenatal care during her current pregnancy, with all prior check-ups indicating a healthy pregnancy without major concerns.
MG is happily married and describes a supportive and loving relationship. She resides in a safe and stable home environment and is currently employed as a part-time teacher. She has a close-knit group of friends and participates in regular social activities. MG denies any history of substance abuse or dependence. She does not smoke, use tobacco products, or consume alcohol.
Family history indicates no significant chronic or hereditary illnesses among parents, siblings, or grandparents. All immediate family members are alive, and there are no indications of hereditary conditions that could impact MG's current health status.
MG has not undergone any previous surgical procedures.
MG has no history of diagnosed mental health disorders such as anxiety, depression, or other psychiatric conditions. She denies concerns related to anxiety or depression and reports no history of self-harm or suicidal or homicidal ideation.
MG reports no concerns about personal safety, domestic violence, or issues related to her or her family's security. She is in a stable and supportive relationship with her husband, and there are no indications of any history of violence or abuse.
MG reports regular menstrual cycles. She is currently at 33 weeks gestation with her first pregnancy and has not experienced any significant pregnancy complications.
General: No significant weight loss, fever, chills, weakness, or fatigue.
HEENT: No visual disturbances, eye pain, or vision changes. She denies hearing loss, tinnitus, or ear pain. No complaints of sore throat or difficulty swallowing.
Skin: Experiences itching, burning, and painful sores in the genital area, correlating with her diagnosis of genital herpes (HSV type 2).
Cardiovascular: No chest pain, palpitations, or edema.
Respiratory: No shortness of breath, cough, or sputum production.
Gastrointestinal: No nausea, vomiting, diarrhea, or abdominal pain. No history of gastrointestinal bleeding.
Neurological: Denies headaches, dizziness, paralysis, syncope, ataxia, numbness, or tingling in the extremities. No reported change in bowel or bladder control.
Musculoskeletal: No muscle pain, back pain, joint pain, or stiffness.
Hematologic: No indications of anemia, bleeding, or bruising.
Lymphatics: No enlarged lymph nodes and no history of splenectomy.
Psychiatric: No history of psychiatric disorders. MG denies any symptoms of depression or anxiety.
Endocrinologic: No issues related to sweating or intolerance to heat or cold. She denies polyuria or polydipsia.
Genitourinary/Reproductive: Reports burning on urination, likely related to her current diagnosis of genital herpes (HSV type 2). Her pregnancy is progressing well without complications.
Allergies: History of occasional seasonal allergies. No known medication, food, or environmental allergies.
The patient's general appearance reveals a well-nourished individual exhibiting no overt signs of acute distress, consistent with a pregnant patient at 33 weeks gestation. Vital signs — including blood pressure, heart rate, respiratory rate, and temperature — all fall within acceptable ranges for a woman in the latter stages of pregnancy, providing reassurance of stable physiological parameters.
The cranial examination reveals no abnormalities; the head appears normocephalic and atraumatic with no tenderness or swelling. The ocular examination is favorable, with pupils equal in size and appropriately reactive to light. Extraocular movements are intact, and the conjunctiva appears pink and moist, indicating no inflammation or dryness. Ear canals are free of discharge, and tympanic membranes are intact with a pearly gray appearance. The nasal examination reveals no deformities or discharge, and the nasal mucosa appears pink and moist. The oropharyngeal region shows no erythema, exudate, or tonsillar enlargement, with the uvula positioned midline. Neck palpation yields a supple response with no detectable lymph nodes or masses.
Cardiovascular evaluation reveals a regular heart rate and rhythm with no murmurs, rubs, or gallops on auscultation. Peripheral pulses are palpable and symmetrical bilaterally. Respiratory assessment is favorable, with regular respiratory effort and clear breath sounds bilaterally, with no wheezing or crackles.
The abdominal examination is of particular importance in the context of pregnancy. Fundal height corresponds to the patient's gestational age, indicating appropriate fetal growth. No tenderness, guarding, or rebound tenderness is noted. Fetal heart tones are positive on auscultation, confirming fetal well-being.
A significant finding on examination of the external genitalia is the presence of multiple painful vesicular lesions consistent with a herpes simplex virus infection. There are no signs of abnormal discharge or erythema beyond the affected area. Cervical examination reveals a closed cervix with no cervical motion tenderness, ruling out overt signs of infection or pregnancy-related complications in that region. Laboratory workup strongly suggests HSV type 2 infection; the combination of clinical presentation and laboratory results — including serological tests, viral culture, or PCR — corroborates the diagnosis. No edema or cyanosis is noted in the extremities, and a full range of motion is observed.
The primary diagnosis of genital herpes (HSV type 2) is supported by the patient's clinical presentation of painful vesicular lesions in the genital area and positive laboratory results confirming HSV type 2 infection. Genital herpes typically manifests as painful vesicular lesions in the genital area (Magdaleno-Tapial et al., 2020). These lesions are characterized by small, fluid-filled blisters that may rupture, leading to shallow ulcers. The affected area is often accompanied by redness and swelling, and patients may report itching and discomfort. Additionally, individuals with genital herpes may experience flu-like symptoms — including fever, headache, and muscle aches — during initial outbreaks.
The American College of Obstetricians and Gynecologists (ACOG) recommends antiviral therapy with medications such as Acyclovir or Valacyclovir for managing genital herpes during pregnancy. Antiviral treatment is essential to control active outbreaks and reduce the risk of neonatal transmission.
Bacterial vaginosis is a differential diagnosis due to its common occurrence during pregnancy and similar symptoms, including vaginal discomfort, itching, and discharge (Ellington & Saccomano, 2020). However, the absence of a fishy odor on examination and the presence of vesicular lesions on physical examination differentiate genital herpes from bacterial vaginosis. ACOG recommends oral or vaginal Metronidazole as the first-line treatment for bacterial vaginosis during pregnancy.
Contact dermatitis is another possible differential diagnosis, as it can manifest with itching and painful sores in the genital area. A careful examination and detailed medical history help differentiate genital herpes from contact dermatitis (Callander et al., 2019). While HSV type 2 infection produces characteristic vesicular lesions, contact dermatitis typically reveals erythematous, inflamed skin without vesicles. Treatment for contact dermatitis involves avoiding the irritant or allergen and using topical corticosteroids to reduce inflammation.
A UTI can present with genital discomfort and a burning sensation during urination, leading to possible confusion with genital herpes (Mathew Jr & Sapra, 2022). However, in UTIs the focus of pain and discomfort is usually related to the urethra and bladder, and no vesicular lesions are observed on examination. A urinalysis and urine culture can confirm the presence of a UTI. Antibiotics such as Amoxicillin, Nitrofurantoin, or Cephalexin are commonly prescribed for UTIs during pregnancy.
Always verify citation format against your institution’s current style guide requirements.